These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 6199140

  • 1. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
    Brown SE, Howard CR, Steward MW, Ajdukiewicz AB, Whittle HC.
    Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
    [Abstract] [Full Text] [Related]

  • 2. Chronic liver disease: the detection and characterization of circulating immune complexes.
    Brown SE, Steward MW, Viola L, Howard CR, Murray-Lyon IM.
    Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
    [Abstract] [Full Text] [Related]

  • 3. Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen.
    Brown SE, Howard CR, Steward MW, Viola L, Murray-Lyon IM.
    Dev Biol Stand; 1983 Aug; 54():391-7. PubMed ID: 6653894
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M.
    Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antigen-specific detection of HBsAG-containing immune complexes in the course of hepatitis B virus infection.
    Pernice W, Sodomann CP, Lüben G, Seiler FR, Sedlacek HH.
    Clin Exp Immunol; 1979 Aug; 37(2):376-80. PubMed ID: 91465
    [Abstract] [Full Text] [Related]

  • 14. [Immunoenzyme analysis of antigen-specific determination of HBsAG-containing circulating immune complexes (CIC HBsAG/IgM and CIC HBsAG/IgG) in blood serum of patients with HBV-infection].
    Sokolenko AA, Shakhanina KL, Kurilov AN.
    Biull Eksp Biol Med; 1992 Feb; 113(2):174-6. PubMed ID: 1377044
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of HBsAg determinants in immune complexes from hepatitis B virus-associated vasculitis.
    Gupta RC, Kohler PF.
    J Immunol; 1984 Mar; 132(3):1223-8. PubMed ID: 6198385
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S, Aizawa R, Abe H, Suto S, Miyakawa Y, Aizawa Y.
    Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.